0001192482-18-000151.txt : 20180404
0001192482-18-000151.hdr.sgml : 20180404
20180404165030
ACCESSION NUMBER: 0001192482-18-000151
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180402
FILED AS OF DATE: 20180404
DATE AS OF CHANGE: 20180404
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Fleming Alison B
CENTRAL INDEX KEY: 0001640701
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37372
FILM NUMBER: 18737860
MAIL ADDRESS:
STREET 1: 780 DEDHAM STREET, SUITE 800
CITY: CANTON
STATE: MA
ZIP: 02021
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: COLLEGIUM PHARMACEUTICAL, INC
CENTRAL INDEX KEY: 0001267565
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: VA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 780 DEDHAM STREET, SUITE 800
CITY: CANTON
STATE: MA
ZIP: 02021
BUSINESS PHONE: 781-713-3699
MAIL ADDRESS:
STREET 1: 780 DEDHAM STREET, SUITE 800
CITY: CANTON
STATE: MA
ZIP: 02021
FORMER COMPANY:
FORMER CONFORMED NAME: COLLEGIUM PHARMACEUTICAL INC
DATE OF NAME CHANGE: 20031020
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2018-04-02
0001267565
COLLEGIUM PHARMACEUTICAL, INC
COLL
0001640701
Fleming Alison B
C/O COLLEGIUM PHARMACEUTICAL, INC.
780 DEDHAM STREET, SUITE 800
CANTON
MA
02021
0
1
0
0
Chief Technology Officer
Common Stock
2018-04-02
4
M
0
4225
.28
A
53541
D
Common Stock
2018-04-02
4
M
0
3917
.28
A
57458
D
Stock option (right to purchase)
.28
2018-04-02
4
M
0
4225
0
D
2024-03-05
Common Stock
4225
0
D
Stock option (right to purchase)
.28
2018-04-02
4
M
0
3917
0
D
2024-03-05
Common Stock
3917
0
D
4,225 option shares are exercisable. The option, initially representing a right to purchase a total of 15,623 shares, vested and became exercisable in equal installments (rounded up to the nearest whole share of common stock) on a monthly basis over a four-year period commencing on March 5, 2014, subject to the reporting person's continued service with the issuer.
3,917 option shares are exercisable. The option, initially representing a right to purchase a total of 14,492 shares, vested and became exercisable over a four-year period commencing on March 5, 2014. Twenty-five percent (25%) of the option vested and became exercisable on March 5, 2015 and the balance vested in equal monthly installments (rounded up to the nearest whole share of common stock) at the end of each monthly period over the remaining three years of the four-year period, subject to the reporting person's continued service with the issuer.
/s/ Paul Brannelly as Attorney-In-Fact For Alison B. Fleming
2018-04-04